Tenor Capital Management’s Biote Corp. Warrant BTMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,000
Closed -$10.5K 449
2023
Q1
$10.5K Hold
25,000
﹤0.01% 345
2022
Q4
$7.5K Hold
25,000
﹤0.01% 450
2022
Q3
$9K Hold
25,000
﹤0.01% 607
2022
Q2
$11K Hold
25,000
﹤0.01% 680
2022
Q1
$14K Hold
25,000
﹤0.01% 791
2021
Q4
$18K Hold
25,000
﹤0.01% 789
2021
Q3
$20K Hold
25,000
﹤0.01% 734
2021
Q2
$26K Buy
+25,000
New +$21.6K ﹤0.01% 765

Other funds holding BTMDW

Tenor Capital Management's BTMDW Position: Q2 2023 in Review

Tenor Capital Management sold out of Biote Corp. Warrant (BTMDW) in Q2 2023, closing a stake of 25,000 shares — an estimated $10.5K sold.

Tenor Capital Management first reported a position in BTMDW in Q2 2021 and held it in 8 quarters. The position peaked at $26K in Q2 2021. 2 funds tracked by Wall St. Rank hold BTMDW as of Q2 2023.

  • Tenor Capital Management reported no remaining Biote Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • Tenor Capital Management sold 25,000 Biote Corp. Warrant shares in Q2 2023, an estimated $10.5K.
  • Tenor Capital Management first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 8 quarters.
  • Tenor Capital Management's Biote Corp. Warrant position peaked at $26K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2023.

Based on Tenor Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.